Library / Laws / 116th Congress / House Bills / H.R. 4244
H.R. 4244
To provide for a pathway for chemically synthesized insulin to be approved under an abbreviated new drug application submitted under the Federal Food, Drug, and Cosmetic Act, and for other purposes.
| Print stage | Date | Size | ⠃ |
|---|---|---|---|
| Introduced in House | 2019-09-09 | 1.8K | ⠃⠗⠋ |